SEC Form 4 · accession 0000899243-18-018684
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alec Barclay
Officer — See Remarks
Period of report
Jun 28, 2018
Accepted (ET)
Jun 29, 2018 · 2:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 28, 2018 | M | 24,086 | $0.00 | A | 34,979 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 15, 2018, the reporting person was granted Performance Restricted Stock Units that vest in the form of common stock based upon the achievement of certain pre-established 90-day average daily closing prices per share goals over a three-year performance period. On June 28, 2018, the Compensation Committee of the Issuer's Board of Directors determined that the performance conditions had been met, resulting in the vesting of these shares.
Remarks
Senior Vice President of Operations